Blog
Featured post
Truveta expands its community to more than 40 healthcare and life science organizations
We are excited to announce the expansion of the Truveta community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously...
Truveta collaboration with Harvard University researchers published in JAMA Network Open
Today Truveta announced a new research letter published in JAMA Network Open using de-identified patient data from Truveta Studio. Published in collaboration with Anupam B. Jena,...
Comparative effectiveness of SGLT2i vs. Metformin for first-line antidiabetic treatment
This blog is an extension of our poster presented at ISPOR, titled Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin as First-Line Therapy in Type 2 Diabetes. ...
How better medical device data can create better patient outcomes
Medical device companies face a unique challenge when they want to study their product performance post-launch – a significant lack of detailed data on use of their device in...
ISPOR 2023: Presenting Truveta Research’s recent type 2 diabetes findings
This post is authored by Tricia Rodriguez, senior applied scientist, Truveta Research. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is gearing up...
The effect of the opioid crisis on babies
Since the 1990s, the negative impact of prescription opioids – particularly death from overdose – have become an epidemic in the US (Centers for Disease Control and Prevention,...
Huddle up: Injury comparisons across sports
While many adults engage in sports, even more children participate in sports (Blendon et al., 2015). A 2020 report suggests that over 50% of children between 6-17 have...
Double play: Multi-injury athletes, by the numbers
With over 3.5 million sport injuries estimated to occur each year (Johns Hopkins Medicine, 2023), we spent the last several weeks digging into and describing injury patterns...
How does approval of a new Alzheimer’s drug impact genetic testing?
The National Institute of Health estimates that more than six million Americans over the age of 65 suffer from Alzheimer’s disease, with many more under the age of 65 also having...